NASS 2019 Annual Meeting

Christopher Shaffrey, MD




Royalties: Medtronic (F), NuVasive (F), Zimmer Biomet (F); Stock Ownership: NuVasive (34000 Shares); Consulting: DePuy Synthes (Outside 12-Month Requirement), K2M (B); Speaking and/or Teaching Arrangements: Stryker Spine (B); Board of Directors: AANS (Travel Expense Reimbursement), CSRS (Nonfinancial), ABNS (Travel Expense Reimbursement); Other Office: ABNS (Chair, Travel Expense Reimbursement); Grants: NIH (C), Department of Defense/ NACTN (F), ISSG (C); Fellowship Support: AO (E), NREF (E).

Sessions :